SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001078782-12-001156
Filing Date
2012-04-30
Accepted
2012-04-27 19:10:39
Documents
3
Group Members
DERMASTAR INTERNATIONAL, LLCMARK L. BAUMROBERT KAMMER

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f13d042712_ex1.htm SC 13D 3948
2 EXHIBIT 1 JOINT FILING AGREEMENT f13d042712_ex2.htm EX-1 20754
3 EXHIBIT 2 WAIVER AGREEMENT f13d042712_sc13d.htm EX-2 71027
  Complete submission text file 0001078782-12-001156.txt   97541
Mailing Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075
Business Address 437 S. HWY 101 STE 209 SOLANA BEACH CA 92075 858-433-2800
Imprimis Pharmaceuticals, Inc. (Subject) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-83793 | Film No.: 12791479
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019
Business Address 1302 WAUGH DRIVE STE 618 HOUSTON TX 77019 8584054448
DERMASTAR INTERNATIONAL, LLC (Filed by) CIK: 0001539513 (see all company filings)

IRS No.: 452840324 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D